Advertisement

Waters introduced the first UltraPerformance LC (UPLC) analytical solution for the characterization of 2-AB labeled glycans from glycoproteins. The UPLC solution combines new ACQUITY UPLC BEH Glycan Columns with the ACQUITY UPLC System equipped with fluorescence detection. Current FDA regulations require that firms developing and manufacturing therapeutic proteins are able to accurately characterize the glycans attached to those proteins to ensure the efficacy and safety of a biopharmaceutical product. Waters Corp., 800-252-4752, www.waters.com
bt0905watersfocus.tif
Advertisement
Advertisement